⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001752059

Kaplan Andrew T.

Reports to the SEC for 2 companies · BOSTON, MA

Transactions

6

Companies

2

Filings

2

CIK

0001752059

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-20	KLRAKailera Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+17.9M sh	—	—	17,857,143
2026-04-20	KLRAKailera Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+8.4M sh	$16.00	+$134M	26,255,581
2026-04-20	KLRAKailera Therapeutics, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−17.9M sh	—	—	0
2026-04-16	KLRAKailera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+38.3K sh	—	—	38,300
2023-12-19	SGRYSurgery Partners, Inc.S Sale	Director, 10% Owner	SSale	−7.83M sh	$33.44	−$262M	50,421,379
2023-12-19	SGRYSurgery Partners, Inc.J Other	Director, 10% Owner	JOther	−474K sh	—	—	49,946,972

Recent filings

2

Accepted (ET)
Apr 204
Kaplan Andrew T.0001193125-26-164388
SEC(opens sec.gov)
Dec 214
Kaplan Andrew T.0000950170-23-072382
SEC(opens sec.gov)

Companies

2

Address

C/O BAIN CAPITAL INVESTORS LLC 200 CLARENDON STREET

BOSTON, MA, 02116